A screening method to assess biological effects of microRNA overexpression in Chinese hamster ovary cells
Abstract
MicroRNAs (miRNAs) are a novel class of short non‐coding RNAs, which negatively regulate target gene expression at post‐transcriptional level. They mediate an important layer of control in the global regulation of gene networks, controlling a broad range of physiological as well as patho‐physiological pathways including development, cancer, metabolism, proliferation, and stress resistance. So far, more than 365 miRNA genes have been identified in CHO cells. The functional analysis of the physiological effect of such large numbers of miRNAs, however, requires an efficient functional screening method. In the current study, we therefore established and evaluated a protocol to perform miRNA overexpression and to screen their effect on bio‐industrially relevant phenotypes, such as growth, viability and productivity, using a recombinant, Epo‐Fc producing CHO cell line. For protocol optimization, four CHO miRNAs (cgr‐miR‐17, cgr‐miR‐221, cgr‐miR‐21, and cgr‐miR‐210) were cloned into small hairpin vectors including a GFP cassette and transfected. After transfection cells were analyzed for growth and productivity over a 4‐day period. Even from this small set of four miRNAs, the overexpression of miR‐17, one of the members of the oncogenic miR‐17‐92 cluster, gave proof of principle that this method enables the identification of miRNA engineering candidates as its overexpression increased the speed of cell proliferation without negatively impacting specific productivity. The here presented method is applicable for medium‐throughput screening for microRNA, miR‐sponge, siRNA, or mRNA overexpression along with detailed functional characterization using the same experimental set up. As the same procedure can be applied to different production cell lines, the protocol can also be used to test for individual, cell line specific responses to microRNAs. Thus our system represents a general platform to functionally screen candidates for rational cell factory design. Biotechnol. Bioeng. 2012; 109:1376–1385. © 2012 Wiley Periodicals, Inc.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Overexpression of the mir-17 microRNA in CHO was shown to augment cell proliferation speed, leading to higher Epo-Fc yield.
“Furthermore, overexpression of the mir-17 microRNA in CHO was shown to augment cell proliferation speed, leading to higher Epo-Fc yield (Jadhav et al., 2012).”
From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Jadhav et al., 2012
Cites
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1932 · Cited by 785 · see citing works
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition
Cloonan, N., Brown, M. K., Steptoe, A. L., Wani, S., Chan, W. L., Forrest, A. R., Kolle, G., Gabrielli, B., & Grimmond, S. M. (2008) · Genome Biology · doi:10.1186/gb-2008-9-8-r127 · Cited by 304 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Therapeutic glycoprotein production in mammalian cells
Lalonde, M.-E., & Durocher, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.028 · Cited by 296 · see citing works
- Authors
- Jadhav, V., Hackl, M., Hernandez Bort, J. A., Wieser, M., Harreither, E., Kunert, R., Borth, N., & Grillari, J.
- Affiliations
- BOKU University (AT)
- Austrian Centre of Industrial Biotechnology (Austria) (AT)
- Corresponding author
- Borth, Nicole
- Grillari, Johannes
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2012-03-22
- Volume
- 109
- Issue
- 6
- Pages
- 1376-1385
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2068160568
- Cited by
- 55
- References
- 2
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 4 · 2014: 10 · 2013: 13 · 2012: 2
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology and Bioengineering (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- microRNA overexpression, CHO cells, functional screening, recombinant protein expression, miR-17, miR-17-92 cluster, cell proliferation, cell viability, product productivity, shRNA, GFP reporter, microRNA sponge, siRNA
- MeSH terms
- Animals, Cricetulus, Gene Expression Regulation, Genetic Testing, Cricetinae, Recombination, Genetic, CHO Cells, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review